Intra Cellular Therapies | 時価総額

Market Capitalization 変化する 日付
Acadia Pharmaceuticals USD 5.14B 1.73B 2023-12
ALKERMES USD 4.63B 36M 2023-12
BioCryst Pharmaceuticals USD 1.23B 115M 2023-12
Biogen USD 37.5B 274M 2023-12
Bristol-Myers Squibb USD 104.4B 16.85B 2023-12
Cytokinetics USD 8.19B 5.36B 2023-12
Esperion Therapeutics USD 340M 235M 2023-12
Gilead Sciences USD 100.94B 7.57B 2023-12
Halozyme Therapeutics USD 4.88B 157M 2023-12
Intra Cellular Therapies USD 6.67B 227M 2024-03
Marinus Pharmaceuticals USD 407M 142M 2023-09
Minerva Neurosciences USD 43M 5M 2023-12
Nektar Therapeutics USD 113M 4M 2023-09
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
RedHill Biopharma USD 4M 7M 2023-06
Supernus Pharmaceuticals USD 1.89B 307M 2024-03
United Therapeutics USD 11.05B 721M 2024-03
Vanda Pharmaceuticals USD 243M 136M 2023-12



Intra Cellular Therapies 時価総額 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Apr 2024.